Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Frangula purshiana bark, commonly known as cascara sagrada, is the dried aged bark of a shrub native to the Pacific Northwest. Traditionally used in herbal medicine as a stimulant laxative for short-term relief of occasional constipation, its primary mechanism involves anthranol glycosides (notably emodin and related compounds) that act on the intestinal wall to increase muscle contractions and promote bowel movements. The FDA previously approved it as an over-the-counter laxative but later withdrew this status due to insufficient evidence of safety and efficacy. It is now primarily available in dietary supplements[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on frangula purshiana bark.